News

doctor talking to an older man sitting on a bed

2026 Aug 06

Radiopharmaceutical May Benefit Patients with Metastatic Prostate Cancer Sooner

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-... Read more

Image of a mouse lung with staining to show blood vessels and dextran

2026 Aug 05

Scientists Identify Tumor-Secreted Protein That Promotes Lung Metastasis

A protein secreted by common cancer types makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer... Read more

2026 Aug 03

A Promising Solution to a Cancer Drug Resistance Problem

A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine. The... Read more

2026 Jul 20

Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method , published June 30 in Leukemia, compares the physical... Read more

2026 Jul 20

Tumor Organoid Tech Advances Toward a Sci-Fi Future

Significant advances have been made in the development of patient-derived tumor organoids for preclinical research, in two new studies led by Weill Cornell Medicine investigators. The advances represent progress in precision... Read more

2026 Jul 16

$2.5 Million Department of Defense Grant Funds Development of Targeted Therapy for Triple-Negative Breast Cancer

Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and... Read more

2026 Jul 10

Cancer Evolution Study Reveals Biology of Glioma Progression

A form of glioma, a type of brain cancer, tends to progress towards greater malignancy due to an increasing tendency of the glioma cells to transform into immature, stem-cell-like states, according to a study led by... Read more

2026 Jul 01

PSA Levels Alone May Not Reflect Prostate Cancer Growth

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely monitor for cancer... Read more

2026 Jul 01

Rare Stem T Cells May Hold the Key to Fighting Chronic Diseases

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged campaign against a chronic condition — like a viral infection, or cancer — the body needs a steady... Read more

Immunofluorescent image of immune cells labeled in red, white and green

2026 Jun 25

Stress-Linked Gut Viruses May Help Tumors Evade the Immune System

Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria, according to a study led by Weill Cornell Medicine investigators... Read more

2026 Jun 22

Colon Cancer Cells May Change Identity to Metastasize

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors,... Read more

2026 Jun 17

Cancer Survivorship and Rehabilitation 101

Thanks to improved diagnostic capabilities and advanced cancer treatments, nearly 1 in 18 Americans is a cancer survivor, according to the American Cancer Society . If you’re one of them, participating in cancer... Read more

Microscopic image of ovarian cancer cells, illustrated in purple

2026 Jun 15

Weill Cornell Medicine Scientist Receives Award for Research on New Ovarian Cancer Targets

Dr. Dan Landau , the Bibliowicz Family Professor of Medicine, and a member of the Sandra and Edward Meyer Cancer Center and the Englander Institute for Precision Medicine at Weill Cornell Medicine, has received a Lotus Award... Read more

immunofluorescent image of immune cells in a prostate tumor

2026 Jun 15

Experimental Treatment Directly Kills Prostate Tumor Cells While Reawakening Antitumor Immunity

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity, according to a preclinical study led by investigators at Weill... Read more

2026 Jun 12

Metal-Free Carbon Monoxide Prodrugs May Help Prevent Cancer’s Deadly Spread

Video of CO Podcast Animation A carefully designed metal-free carbon monoxide prodrug—an inactive compound that is converted into its active form in the body—may help prevent some of the deadliest forms of cancer from... Read more

space filling model of transcription factor bound to DNA

2026 Jun 04

A Breakthrough Single-Cell Method for Mapping DNA-Protein Interactions

A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by investigators at Weill Cornell... Read more

2026 Jun 03

Oral Drug Combination Eases Treatment Burden for AML Patients

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or... Read more

2026 Jun 02

Here’s What We Know: How an Oncology Patient Navigator Can Help You

If you’ve been diagnosed with cancer, you likely have questions. Oncology navigators offer answers and more. Also called patient navigators or oncology navigators, these caring experts walk alongside cancer patients... Read more

2026 May 28

Grant Aims to Transform Care for Young Cancer Survivors

Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop innovative support strategies for an understudied group of cancer... Read more

2026 May 21

Targeting Inflammation May Help Overcome Drug Resistance in Colon Cancer

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center... Read more